HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Speaker at Pharmaceutical Conference - Geetanjali Sageena
Indian Council of Medical Research, India
Title : Artificial intelligence based strategy for personalized medicine


While AI technologies are rapidly developing in medicine, their implementation in daily care is not yet a reality and we should not be overwhelmed by the challenges we face, but instead use resources to develop AI concepts in pharmacogenomic therapies, to make them safer and more practical, and therefore more beneficial for everyone. Adverse drug reactions place a significant burden on the global healthcare system, yet a significant proportion of adverse drug reactions go unreported, leading to bottlenecks in getting proper treatment. This problem is much more pronounced in lower-middle-income countries (LMICs). Despite significant improvements in adverse reaction reporting, the adverse reaction reporting rate remains high with a well-organized pharmacovigilance program in a country like India. An even greater focus on training healthcare professionals in knowledge-based attitudes and practices is likely to further improve adverse event reporting and lead to safer drug use. Combining pharmacogenomics data with artificial intelligence offers exciting opportunities to identify key clinical execution gaps that link rare variants to patient care.


Geetanjali Sageena completed her graduation and post-graduation from the University of Delhi in 2008 and 2010 respectively. She did her Ph.D. from the Department of Zoology, University of Delhi in 2016. She has worked as an Assistant professor at Keshav Mahavidyalaya, University of Delhi. Currently, she is working as Scientist B with the Indian Council of Medical Research Delhi headquarters. Her research interests are focused on Genomics and Human Health. She has published more than 25 research articles in various journals of repute.